DBV Technologies S.A. has grown revenue 5.2% a year over three years and −13% a year over five. Revenue growth, 3-year annual rate: +5.2% (Biotechnology median +17%). Revenue growth, 5-year rate: −13%, growth has picked up over the last three years. Years of annual history on file: 7, FY2019 to FY2025, as filed.

DBVTDBV Technologies S.A.

Healthcare

$9.51-33% 1Y

$9.51

$9.5152 weeks$24.54

Latest close: a new 52-week lowOct 8, 2026what changed →

Is it growing?

Mixed

Neither accelerating nor breaking down: revenue growing +29% year on year, but operating margin narrowing (−1801.9 points).

1 good, 1 to watch, 1 without data

Revenue trend+29% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings.

Margin direction−1801.9 points operating

Trailing-twelve-month operating margin, -5192.8% now against -3390.9% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is DBVT growing?

DBV Technologies S.A. has grown revenue 5.2% a year over three years and −13% a year over five.

+5.2%

Revenue growth, 3-year annual rate · Biotechnology median +17% · steady growth, ahead of inflation · compounded from fiscal-year columns as filed

Revenue growth, 5-year rate: −13%
Revenue growth, 5-year rate · +5.2% over three · growth has picked up over the last three years
Years of annual history on file: 7
Years of annual history on file · FY2019 to FY2025, as filed

Details›